MAILPAN
LIVE

Serial Number

79210812

Owner

DEFYMED

Attorney

L. Jeremy Craft

Filing Date

Jan 9, 2017

Add to watchlist:

No watchlists yet
View on USPTO

MAILPAN Trademark

Serial Number: 79210812 • Registration: 5494493

MAILPAN is a trademark filed by DEFYMED on January 9, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

DEFYMED (3 trademarks)

9 rue Albert Calmette

Entity Type: 99

Trademark Details

Filing Date

January 9, 2017

Registration Date

June 19, 2018

Published for Opposition

April 3, 2018

Cancellation Date

January 3, 2025

Goods & Services

Human and animal cells for medical use; stem cells for medical or veterinary use; cultures of microorganisms for medical or veterinary use; biological tissue cultures for medical or veterinary use; enzymes for medical or veterinary use; vascular grafts of living tissues; hormones for medical use; surgical implants composed of living tissue; medicines for intestinal disorders in humans; biological preparations for medical or veterinary use in treating metabolic disorders; chemical-pharmaceutical preparations for the treatment of diabetes; chemical preparations for medical or veterinary use for the treatment of diabetes; chemical preparations for pharmaceutical use in the treatment of diabetes; preparations of microorganisms for medical and veterinary use in the treatment of diabetes; diagnostic preparations for medical or veterinary use

Conducting clinical trials for others in the fields of medical devices and pharmaceuticals; research and development of new products for others; research and development in the field of bioartificial medical devices; research and development in the field of microorganisms and cells; research and development in the field of therapeutics; biological research services; bacteriological research services; chemical research; scientific research; technical research in the field of pharmaceutical studies; services provided by consultants relating to scientific research and development in the field of therapeutics; scientific laboratory services

Surgical and medical apparatus and instruments for use in implanting insulin injectors; catheters; implantable devices for the subcutaneous release of medicated substances sold empty; surgical implants comprised of artificial materials; vacuum pumps for medical use; injector devices for medical use in delivering pharmaceuticals

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Mar 5, 2026 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 16, 2026 INTS
INVALIDATION PROCESSED
Feb 16, 2026 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 10, 2025 INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 3, 2025 INTR
CANCELLED SECTION 71
Jan 3, 2025 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 19, 2023 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 11, 2021 ADCH
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 1, 2019 TCCA
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 12, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 22, 2018 FICS
FINAL DISPOSITION PROCESSED
Sep 22, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 19, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 19, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 3, 2018 NPUB
PUBLISHED FOR OPPOSITION
Apr 3, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Mar 30, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 14, 2018 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 14, 2018 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 14, 2018 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 26, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 30, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 30, 2018 CRFA
ASSIGNED TO LIE
Jan 25, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 11, 2018 TROA
REFUSAL PROCESSED BY IB
Aug 4, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 15, 2017 RFCS
REFUSAL PROCESSED BY MPU
Jul 15, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 8, 2017 RFCR
NON-FINAL ACTION WRITTEN
Jul 7, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Jul 4, 2017 MAFR
ASSIGNED TO EXAMINER
Jun 30, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 30, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 29, 2017 REPR